Quidel Molecular Direct HSV 1+2/VZV
The Quidel® Molecular Direct HSV 1+2/VZV Assay is a multiplex real-time PCR assay for the qualitative detection and identification of viral nucleic acids extracted from lesion swabs. The assay is intended to aid in the differential diagnosis of Herpes simplex virus 1 and 2 (HSV-1 and HSV-2) and Varicella-zoster virus (VZV) also known as Human Herpes-3. VZV is the virus that causes chicken pox.
Benefits of Quidel® Molecular Direct HSV 1+2/VZV Kits
|Genital herpes is misdiagnosed 20% of the time1|
|In the US, 16 percent of adults are HSV-2 seropositive, but only 10 percent to 25 percent of persons with HSV-2 infection have recognized genital herpes. Moreover, most HSV-2 infections are acquired from persons without a clinical history of genital herpes 1|
|Early identification can reduce transmission and suppress reactivation2|
|Plans can be made to avoid transmission to neonates|
|Quidel® Molecular Direct HSV 1+2/VZV Assay
(For sale in Europe only. The assay is validated on the QuantStudio™ Dx and the 7500 Fast Dx Real-time Instruments in Europe)
|Quidel Molecular HSV/VZV External Controls||10-reactions||4481484|
Hook, Edward W. III. 2012. “A New Look at Genital Herpes: The Critical Role of the Laboratory in Diagnosis and Management.” Medical Laboratory Observer. 2012 July 44(7):8-12.
- Emmert, David. 2000. “Treatment of Common Cutaneous Herpes Simplex Virus Infections”. American Family Physician. 2000.